Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.37 AUD 4.23% Market Closed
Market Cap: 154.7m AUD

Relative Value

The Relative Value of one SPL stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.37 AUD, Starpharma Holdings Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
50
vs Industry
14
Median 3Y
11.1
Median 5Y
30.2
Industry
2.7
Forward
9.7
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-13.4
Industry
21.6
Forward
-0.6
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-16.7
Industry
16.9
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-19.3
Industry
22.9
vs History
17
vs Industry
43
Median 3Y
2
Median 5Y
4.8
Industry
2.3
vs History
49
vs Industry
24
Median 3Y
6.6
Median 5Y
24.8
Industry
3
Forward
8.4
vs History
50
vs Industry
32
Median 3Y
8.1
Median 5Y
32.3
Industry
5.6
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-10.6
Industry
13.4
Forward
-83.3
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-10.6
Industry
16.7
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-14.7
Industry
16.1
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-14.5
Industry
18.9
vs History
47
vs Industry
23
Median 3Y
4.1
Median 5Y
19.8
Industry
2

Multiples Across Competitors

SPL Competitors Multiples
Starpharma Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Starpharma Holdings Ltd
ASX:SPL
154.7m AUD 26.5 -15.5 -14.1 -14.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
504.6B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
270.7B CHF 4.4 28.7 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
217.2B GBP 5 31.1 109.3 159.9
CH
Novartis AG
SIX:NOVN
218B CHF 4.9 19 12 15.5
US
Merck & Co Inc
NYSE:MRK
271.6B USD 4.2 14.3 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.5 11.4 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
AU
Starpharma Holdings Ltd
ASX:SPL
Average P/E: 25
Negative Multiple: -15.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.1
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.3
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.5
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Starpharma Holdings Ltd
ASX:SPL
Average EV/EBITDA: 440.1
Negative Multiple: -14.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109.3
10%
10.9
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
1%
11.4
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Starpharma Holdings Ltd
ASX:SPL
Average EV/EBIT: 1 883.8
Negative Multiple: -14.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.9
23%
7
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5